Eupraxia Pharmaceuticals Inc

NEW
TSX:EPRX (Canada)   Ordinary Shares
C$ 9.32 +0.23 (+2.53%) Aug 13
At Loss
P/B:
4.29
Market Cap:
C$ 612.71M ($ 441.35M)
Enterprise V:
C$ 467.90M ($ 337.05M)
Volume:
53.29K
Avg Vol (2M):
68.98K
Trade In:
Volume:
53.29K
At Loss
Avg Vol (2M):
68.98K

Eupraxia Pharmaceuticals Inc (TSX:EPRX) Dividend

Eupraxia Pharmaceuticals Inc (TSX:EPRX) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -34%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: TSX:EPRX Dividend

Does Eupraxia Pharmaceuticals Inc (TSX:EPRX) pay a dividend?

Eupraxia Pharmaceuticals Inc (TSX:EPRX) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Eupraxia Pharmaceuticals Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Eupraxia Pharmaceuticals Inc has returned capital to shareholders via buybacks at a rate of -34% over the past 3 years.

What are dividend-paying alternatives to Eupraxia Pharmaceuticals Inc?

For dividend-paying alternatives in Eupraxia Pharmaceuticals Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.